Role  ||| S:0 E:5 ||| NN
of  ||| S:5 E:8 ||| IN
calcium-sensing  ||| S:8 E:24 ||| JJ
receptor  ||| S:24 E:33 ||| NN
in  ||| S:33 E:36 ||| IN
bone  ||| S:36 E:41 ||| FW
biology  ||| S:41 E:49 ||| FW
Extracellular  ||| S:49 E:63 ||| FW
calcium  ||| S:63 E:71 ||| FW
concentration  ||| S:71 E:85 ||| FW
changes  ||| S:85 E:93 ||| NNS
are  ||| S:93 E:97 ||| VBP
recognized  ||| S:97 E:108 ||| VBN
by  ||| S:108 E:111 ||| IN
Ca++  ||| S:111 E:116 ||| FW
sensing  ||| S:116 E:124 ||| FW
receptor  ||| S:124 E:133 ||| FW
( ||| S:133 E:134 ||| -LRB-
CaR ||| S:134 E:137 ||| NNP
) ||| S:137 E:138 ||| -RRB-
,  ||| S:138 E:140 ||| ,
a  ||| S:140 E:142 ||| DT
member  ||| S:142 E:149 ||| NN
of  ||| S:149 E:152 ||| IN
the  ||| S:152 E:156 ||| DT
G-protein-coupled  ||| S:156 E:174 ||| JJ
receptor  ||| S:174 E:183 ||| NN
family ||| S:183 E:189 ||| NN
.  ||| S:189 E:191 ||| .
Recently ||| S:191 E:199 ||| RB
,  ||| S:199 E:201 ||| ,
progress  ||| S:201 E:210 ||| NN
has  ||| S:210 E:214 ||| VBZ
been  ||| S:214 E:219 ||| VBN
made  ||| S:219 E:224 ||| VBN
in  ||| S:224 E:227 ||| IN
the  ||| S:227 E:231 ||| DT
understanding  ||| S:231 E:245 ||| NN
of  ||| S:245 E:248 ||| IN
CaR  ||| S:248 E:252 ||| JJ
functional  ||| S:252 E:263 ||| JJ
role  ||| S:263 E:268 ||| NN
in  ||| S:268 E:271 ||| IN
bone  ||| S:271 E:276 ||| NN
cells ||| S:276 E:281 ||| NNS
,  ||| S:281 E:283 ||| ,
notwithstanding  ||| S:283 E:299 ||| IN
a  ||| S:299 E:301 ||| DT
lack  ||| S:301 E:306 ||| NN
of  ||| S:306 E:309 ||| IN
detailed  ||| S:309 E:318 ||| JJ
knowledge  ||| S:318 E:328 ||| NN
about  ||| S:328 E:334 ||| IN
the  ||| S:334 E:338 ||| DT
identity  ||| S:338 E:347 ||| NN
of  ||| S:347 E:350 ||| IN
the  ||| S:350 E:354 ||| DT
cation  ||| S:354 E:361 ||| JJ
receptors ||| S:361 E:370 ||| NNS
.  ||| S:370 E:372 ||| .
It  ||| S:372 E:375 ||| PRP
is  ||| S:375 E:378 ||| VBZ
generally  ||| S:378 E:388 ||| RB
agreed  ||| S:388 E:395 ||| VBN
that  ||| S:395 E:400 ||| IN
a  ||| S:400 E:402 ||| DT
high  ||| S:402 E:407 ||| JJ
extracellular  ||| S:407 E:421 ||| JJ
calcium  ||| S:421 E:429 ||| NN
induces  ||| S:429 E:437 ||| VBZ
osteoblast  ||| S:437 E:448 ||| JJ
proliferation  ||| S:448 E:462 ||| NN
and  ||| S:462 E:466 ||| CC
osteoclastogenesis  ||| S:466 E:485 ||| JJ
inhibition ||| S:485 E:495 ||| NN
.  ||| S:495 E:497 ||| .
Potential  ||| S:497 E:507 ||| JJ
implications  ||| S:507 E:520 ||| NNS
that  ||| S:520 E:525 ||| WDT
may  ||| S:525 E:529 ||| MD
be  ||| S:529 E:532 ||| VB
considered  ||| S:532 E:543 ||| VBN
include  ||| S:543 E:551 ||| VBP
a  ||| S:551 E:553 ||| DT
role  ||| S:553 E:558 ||| NN
for  ||| S:558 E:562 ||| IN
CaR  ||| S:562 E:566 ||| JJ
in  ||| S:566 E:569 ||| IN
osteogenesis ||| S:569 E:581 ||| NN
,  ||| S:581 E:583 ||| ,
in  ||| S:583 E:586 ||| IN
serum  ||| S:586 E:592 ||| JJ
calcium  ||| S:592 E:600 ||| NN
homeostasis  ||| S:600 E:612 ||| NN
regulation ||| S:612 E:622 ||| NN
,  ||| S:622 E:624 ||| ,
and  ||| S:624 E:628 ||| CC
as  ||| S:628 E:631 ||| IN
a  ||| S:631 E:633 ||| DT
factor  ||| S:633 E:640 ||| NN
coupling  ||| S:640 E:649 ||| NN
bone  ||| S:649 E:654 ||| NN
formation  ||| S:654 E:664 ||| NN
to  ||| S:664 E:667 ||| TO
resorption  ||| S:667 E:678 ||| VB
in  ||| S:678 E:681 ||| IN
bone  ||| S:681 E:686 ||| NN
remodeling ||| S:686 E:696 ||| NN
.  ||| S:696 E:698 ||| .
The  ||| S:698 E:702 ||| DT
localization  ||| S:702 E:715 ||| NN
of  ||| S:715 E:718 ||| IN
CaR  ||| S:718 E:722 ||| JJ
in  ||| S:722 E:725 ||| IN
bone  ||| S:725 E:730 ||| NN
cells  ||| S:730 E:736 ||| NNS
provides  ||| S:736 E:745 ||| VBZ
further  ||| S:745 E:753 ||| JJ
knowledge  ||| S:753 E:763 ||| NN
of  ||| S:763 E:766 ||| IN
the  ||| S:766 E:770 ||| DT
mechanisms  ||| S:770 E:781 ||| JJ
operating  ||| S:781 E:791 ||| NN
in  ||| S:791 E:794 ||| IN
the  ||| S:794 E:798 ||| DT
bone  ||| S:798 E:803 ||| NN
remodeling  ||| S:803 E:814 ||| NN
model ||| S:814 E:819 ||| NN
;  ||| S:819 E:821 ||| :
in  ||| S:821 E:824 ||| IN
fact ||| S:824 E:828 ||| NN
,  ||| S:828 E:830 ||| ,
increased  ||| S:830 E:840 ||| VBD
calcium  ||| S:840 E:848 ||| JJ
gradient  ||| S:848 E:857 ||| NN
in  ||| S:857 E:860 ||| IN
the  ||| S:860 E:864 ||| DT
site  ||| S:864 E:869 ||| NN
of  ||| S:869 E:872 ||| IN
bone  ||| S:872 E:877 ||| FW
resorption  ||| S:877 E:888 ||| FW
favors  ||| S:888 E:895 ||| FW
osteoblast  ||| S:895 E:906 ||| FW
precursors  ||| S:906 E:917 ||| FW
chemotaxis  ||| S:917 E:928 ||| FW
and  ||| S:928 E:932 ||| CC
inhibits  ||| S:932 E:941 ||| JJ
osteoclasts  ||| S:941 E:953 ||| NN
through  ||| S:953 E:961 ||| IN
the  ||| S:961 E:965 ||| DT
increase  ||| S:965 E:974 ||| NN
of  ||| S:974 E:977 ||| IN
[ ||| S:977 E:978 ||| -LRB-
Ca++ ||| S:978 E:982 ||| NNP
] ||| S:982 E:983 ||| -RRB-
e ||| S:983 E:984 ||| NN
.  ||| S:984 E:986 ||| .
In  ||| S:986 E:989 ||| IN
vitro  ||| S:989 E:995 ||| JJ
data  ||| S:995 E:1000 ||| NNS
indicate  ||| S:1000 E:1009 ||| VBP
that  ||| S:1009 E:1014 ||| IN
CaR  ||| S:1014 E:1018 ||| NNP
is  ||| S:1018 E:1021 ||| VBZ
a  ||| S:1021 E:1023 ||| DT
physiological  ||| S:1023 E:1037 ||| JJ
regulator  ||| S:1037 E:1047 ||| NN
of  ||| S:1047 E:1050 ||| IN
bone  ||| S:1050 E:1055 ||| NN
cells ||| S:1055 E:1060 ||| NNS
,  ||| S:1060 E:1062 ||| ,
regulating  ||| S:1062 E:1073 ||| VBG
the  ||| S:1073 E:1077 ||| DT
recruitment ||| S:1077 E:1088 ||| NN
,  ||| S:1088 E:1090 ||| ,
differentiation  ||| S:1090 E:1106 ||| NN
and  ||| S:1106 E:1110 ||| CC
survival  ||| S:1110 E:1119 ||| NN
of  ||| S:1119 E:1122 ||| IN
osteoblasts  ||| S:1122 E:1134 ||| NN
and  ||| S:1134 E:1138 ||| CC
osteoclasts ||| S:1138 E:1149 ||| NN
.  ||| S:1149 E:1151 ||| .
This  ||| S:1151 E:1156 ||| DT
leads  ||| S:1156 E:1162 ||| VBZ
to  ||| S:1162 E:1165 ||| TO
the  ||| S:1165 E:1169 ||| DT
concept  ||| S:1169 E:1177 ||| NN
that  ||| S:1177 E:1182 ||| IN
the  ||| S:1182 E:1186 ||| DT
CaR  ||| S:1186 E:1190 ||| JJ
present  ||| S:1190 E:1198 ||| NN
in  ||| S:1198 E:1201 ||| IN
bone  ||| S:1201 E:1206 ||| NN
cells  ||| S:1206 E:1212 ||| NNS
may  ||| S:1212 E:1216 ||| MD
be  ||| S:1216 E:1219 ||| VB
targeted  ||| S:1219 E:1228 ||| VBN
by  ||| S:1228 E:1231 ||| IN
agonists  ||| S:1231 E:1240 ||| NN
or  ||| S:1240 E:1243 ||| CC
antagonists  ||| S:1243 E:1255 ||| NNS
to  ||| S:1255 E:1258 ||| TO
control  ||| S:1258 E:1266 ||| VB
bone  ||| S:1266 E:1271 ||| JJ
cell  ||| S:1271 E:1276 ||| NN
metabolism  ||| S:1276 E:1287 ||| NN
and  ||| S:1287 E:1291 ||| CC
bone  ||| S:1291 E:1296 ||| NN
remodeling ||| S:1296 E:1306 ||| NN
.  ||| S:1306 E:1308 ||| .
